Expression of the ␥-globin gene is silenced in adult humans. However, certain point mutations in the ␥-globin gene promoter are capable of maintaining expression of this gene during adult erythropoiesis, a condition called non-deletion hereditary persistence of fetal hemoglobin (HPFH). Among these, the British form of HPFH carrying a T 3 C point mutation at position ؊198 of the A ␥-globin gene promoter results in 4 -10% fetal hemoglobin in heterozygotes. In this study, we used nuclear extracts from murine erythroleukemia cells to purify a protein complex that binds the HPFH ؊198 ␥-globin gene promoter. Members of this protein complex were identified by mass spectrometry and include DNMT1, the transcriptional coactivator p52, the protein SNEV, and RAP74 (the largest subunit of the general transcription factor IIF). Sp1, which was previously considered responsible for HPFH ؊198 ␥-globin gene activation, was not identified. The potential role of these proteins in the reactivation and/or maintenance of ␥-globin gene expression in the adult transcriptional environment is discussed.The human -globin gene cluster consists of five functional globin genes (⑀, G ␥, A ␥, ␦, and ) arranged in the locus according to the order of their expression during development. Genetic and biochemical evidence indicates that the expression of these genes during development depends on interactions between the individual globin gene promoters and the locus control region located 6 -22 kb upstream of the ⑀-globin gene (1). Two developmental expression switches occur in the -globin locus: one from the embryonic ⑀ gene to the fetal ␥ genes and later from the fetal ␥ genes to adult ␦ and  genes. Adult individuals express very low levels of the ␥-globin genes (usually ϳ0.5% of the total hemoglobin). However, single point mutations occurring in either the G ␥-or A ␥-globin gene promoter result in continued expression of the ␥ gene in the adult, a condition termed non-deletion hereditary persistence of fetal hemoglobin (HPFH) 3 (reviewed in Refs. 1 and 2). Structural studies have shown that non-deletion HPFH point mutations are clustered in three regions of the ␥ gene promoters centered around positions Ϫ200, Ϫ175, and Ϫ115 relative to the transcriptional start site (2). The Ϫ200 region is a highly GC-rich region known to be the target for five different but closely spaced point mutations affecting the G ␥ promoter at position Ϫ202 (C 3 G) and the A ␥ promoter at position Ϫ202 (C 3 T), Ϫ198 (T 3 C), Ϫ196 (C 3 T), or Ϫ195 (C 3 G), respectively (1, 2). Two hypotheses have been proposed to explain the increased ␥-globin gene expression in adults carrying non-deletion HPFH mutations. The first proposes that these point mutations decrease the binding of a transcriptional repressor or a complex that is involved in the silencing of ␥-globin expression in the adult. Alternatively, these mutations may create binding sites that enhance the binding for a transcriptional activator or complex, thus increasing ␥ gene expression in the adult. Early in vit...